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Abstract
Background: The Plasmodium falciparum NA+/H+ exchanger (pfnhe1, gene PF13_0019) has recently been
proposed to influence quinine (QN) susceptibility. However, its contribution to QN resistance seems to vary
geographically depending on the genetic background of the parasites. Here, the role of this gene was investigated
in in vitro QN susceptibility of isolates from Viet Nam.
Method: Ninety-eight isolates were obtained from three different regions of the Binh Phuoc and Dak Nong
bordering Cambodia provinces during 2006-2008. Among these, 79 were identified as monoclonal infection and
were genotyped at the microsatellite pfnhe1 ms4760 locus and in vitro QN sensitivity data were obtained for 51
isolates. Parasite growth was assessed in the field using the HRP2 immunodetection assay.
Results: Significant associations were found between polymorphisms at pfnhe1 microsatellite ms4760 and
susceptibility to QN. Isolates with two or more DNNND exhibited much lower susceptibility to QN than those
harbouring zero or one DNNND repeats (median IC50 of 682 nM versus median IC50 of 300 nM; p = 0.0146) while
isolates with one NHNDNHNNDDD repeat presented significantly reduced QN susceptibility than those who had
two (median IC50 of 704 nM versus median IC50 of 375 nM; p < 0.01). These QNR associated genotype features
were mainly due to the over representation of profile 7 among isolates (76.5%). The majority of parasites had
pfcrt76T and wild-type pfmdr1 (> 95%) thus preventing analysis of associations with these mutations. Interestingly,
area with the highest median QN IC50 showed also the highest percentage of isolates carrying the pfnhe1
haplotype 7.
Conclusions: The haplotype 7 which is the typical Asian profile is likely well-adapted to high drug pressure in this
area and may constitute a good genetic marker to evaluate the dissemination of QNR in this part of the world.
Background
Quinine (QN), an alkaloid from Cinchona Bark, is still a
major anti-malarial drug especially for the treatment of
severe or complicated malaria cases [1]. However,
decreased sensitivity to QN has been reported, especially
in South-East Asia [2-5], and the impact of this drug on
malaria parasite genomes has been difficult to evaluate
to date. There are some evidences suggesting that QN
resistance is a multifactorial mechanism, which includes
at least mutations in transporter genes pfcrt (Plasmo-
dium falciparum chloroquine resistance transporter)
and pfmdr1 (P. falciparum multidrug resistance 1)
[6-14]. In vitro genetic and physiological studies have
suggested that the P. falciparum sodium/hydrogen
exchanger (pfnhe1) gene (PF13_0019) might also contri-
bute to QN resistance [8,11,14]. Studies carried out on
P. falciparum strains from several parts of the world
provide evidence of significantly reduced QN activity in
parasites harbouring two or more DNNND repeated
motif in the coding microsatellite ms4760 of pfnhe1
[8,15]. Some of them further supported an association
between decreased number of another repeated motif
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NHNDNHNNDDD and increased IC50 to QN [15]. In a
series of 60 culture-adapted isolates from the China-
Myanmar border, the involvement of DNNND and
NHNDNHNNDDD in reduced QN susceptibility was
confirmed [16]. However, these results were conflicting
with those obtained with African isolates. Some studies
carried out on field isolates from the Kenyan cost [17]
and Uganda [18] have shown that reduced QN suscept-
ibility was associated with two DNNND repeats com-
bined with pfmdr1 mutations, whereas the presence of 1
versus 3 and 2 versus 3 DNNND repeats was associated
with the restoration of QN susceptibility. In the other
hand, no reliable association between pfnhe1 poly-
morphisms and in vitro QN response was observed in
isolates from various African countries [19,20]. In
Africa, QN treatment is still effective and QN resistance
is much less frequently found than in Asia. As recently
reviewed in Okombo et al [21] African isolates show
lower IC50 values (20 to 600 nM), while in South-East
Asia, IC50 can reach values above 1200 nM. Thus, to
validate pfnhe1 as a genetic marker of QN resistance in
the field, more studies using samples from South East
Asia with reduced susceptibility to QN are needed.
Moreover, some of these studies included isolates col-
lected from disparate regions with different drug history
and over a longer period. Also, evaluation of parasites
after culture adaptation may include a bias in the
selected genotypes as different parasite populations in
the same sample do not thrive equally well in in vitro
culture [22,23]. In this work, the association between
pfnhe1 polymorphism and in vitro QN susceptibility of
fresh clinical P. falciparum isolates collected from a sin-
gle geographical region along the Viet Nam-Cambodia
border was investigated. In vitro tests were conducted
using an mobile laboratory set up in the field to opti-
mize the time gap between the collection of blood sam-
ples on patients and the culturing of these samples.
Methods
All culture and ELISA procedures were performed at a
small temporary field laboratory set up at the dispensary
of Bom Bo in Binh Phuoc province. Blood samples were
transported at +4°C within 12 hours of collection. Sam-
ples for PCR genotyping were frozen at -20°C until ship-
ment to the UMR-MD3 laboratory, Marseille, France.
Study site
The study was conducted in two neighbouring regions
bordering Cambodia: the Binh Phuoc province in the
South-East and the Dak Nong province in the Centre of
Viet Nam (Figure 1). To ensure sufficient sample
recruitment within the timeframe in view of the low
population density and transportation difficulties, four
sites were chosen in 20-25 km radius of the clinic of
Bom Bo. All are situated in hilly and forested parts of
Binh Phuoc and Dak Nong provinces. These areas are
highly endemic and it is a region where multidrug resis-
tance to anti-malarials has spread [1,24].
Patients and clinical samples
Isolates were obtained from patients attending in com-
mune health centres for uncomplicated malaria by col-
lecting venous blood sample (7 ml) in VacutainerÒ
tubes coated with EDTA (Vacutainer tubes, Becton
Dickinson, Rutherford, NJ). Malaria positivity was evalu-
ated by using rapid diagnostic based on the detection of
Plasmodium-specific lactate dehydrogenase (pLDH)
(OptiMAL-IT, DiaMed AG, Switzerland). Patients gave
their consent for this study and were questionned about
socio-demographic data and drug intake. The study was
approved by the Viet Nam People’s Army Department
of Military Medicine. Positive patients were treated with
dihydroartemisinin-piperaquine combination in accor-






Figure 1 Map of malaria monitoring sites in Phuoc Long and
Bu dang districts (Binh Phuoc province) and Dak R’Lap district
(Dak Nong province), Vietnam. * The mobile laboratory was set
up at the dispensary in Bom Bo.
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Mobile laboratory
The mobile laboratory was send to Ho Chi Minh City
(Viet Nam) from Marseille (France) using a commercial
flight, and then transported to the clinic of Bom Bo
(about 130 km north from HCMC) on a pick-up by the
Vietnamese army. It was constituted by four comparti-
mented boxes (350 kg; 2 m3) outfitted for the assess-
ment of P. falciparum susceptibility to anti-malarials.
These boxes, which composed the lab environment,
contained a mini-class II biological safety cabinet, an
incubator chamber equipped with N2 and CO2 gaz bot-
tles (5 L steel cylinders), a microscope, a centrifuge, a
field-suitable ELISA plate washer (Hydroflex Platform,
Tecan, Austria) and plate reader (Sunrise Absorbance
Reader, Tecan, Austria). It also contained a generator
(SHX1000, Elemax, Japan) and an inverter to protect all
the electrical apparatus. The lab unit was completed by
a cold chain to keep in vitro microtest plates and
ELISA reagents at +4°C, and culture reagents at - 20°C
during the transport. Once on site, the mobile labora-
tory was placed in a covered place. Mains electricity
was used, and a generator in case of power cut. A
refrigerator and a deep freeze were installed for the sto-
rage of reagents.
In vitro drug assay
In vitro microtest plates were prepared at UMR-MD3,
Marseille, France and the quality controls were per-
formed with the QN-sensitive 3D7 (unknown origin,
MR4-ATCC) and QN-resistant K1 (Thailand, MR4-
ATCC) and Dd2 (Indochina, MR4-ATCC) strains using
the isotopic microtest method [25]. Final drug concen-
trations ranged from 12.5 to 3200 nM.
In the field, blood samples were washed once with
parasite culture medium and immediately transferred to
in vitro pre-dosed drug plates as described previously
[26]. The plates were incubated at 37°C in presence of
5% CO2, 85% N2 and 10% O2 for 72 h. After culture the
plates were frozen down at -20°C. Parasite growth inhi-
bition was quantified using a commercial HRP2 ELISA
kit (Malaria Ag CELISA; Cellabs, Australia) according to
the manufacturer’s specifications. Spectrophotometric
analysis was performed using a small, field-suitable
ELISA plate reader (Tecan Sunrise Absorbance Reader,
Tecan Austria, Austria) at an absorbance of 450 nm.
Molecular analysis
Parasite DNA was extracted from blood samples using
QIAamp DNA minikit (Qiagen, Germany).
Parasite samples were genotyped at six microsatellites
loci Pf2689 (chr. 12, Genbank ID G37854), Pf2802 (chr.
5, G37818), C4M69 (chr. 4, Genbank ID G37956),
C4M79 (chr. 3, Genbank ID G42726), TRAP (chr. 13,
Genbank ID G37858) and 7A11 (chr. 7, Genbank ID
G38831) using previously described method [27].
PCR conditions used to detect polymorphism in pfcrt
at codon 76 and pfmdr1 at codons 86, 184, 1034, 1042
and 1246 were as described elsewhere [28]. Pfnhe1 was
amplified by PCR using a reaction volume of 25 μL con-
taining 2.5 μL of sample DNA, 0.3 μM of each primer
(NHE-F: 5’-AATCCCTGTTGATATATCG-3’ and NHE-
R: 5’-GTCTTGCAGTGCATGGACC-3’), 200 μM of
dNTPs, 4 mM MgCl2, 1 U GoldStar DNA polymerase
(Eurogentec, Seraing, Belgium), PCR buffer 10 × (750
mM Tris-HCl pH 8.8, 200 mM (NH4)2SO4, 0.1% (v/v)
Tween 20 and stabilizer) (Eurogentec, Seraing, Belgium).
The PCR assay was performed for 40 cycles at 94°C for
20 sec, 50°C for 20 sec and 72°C for 40 sec. The dena-
turation and final extension were carried out at 94°C for
5 min and at 72°C for 5 min, respectively. PCR products
were purified using High Pure PCR Product Purification
Kit (Roche Diagnostics, Meylan, France) and sequenced
with the ABI PRISM Big Dye Terminator v3.1 Cycle
Sequencing Kit (Applied Biosystems, Foster City, CA,
USA). Fluorescent sequence products were analysed by
an ABI PRISM 3100 Genetic Analyzer (Applied
Biosystems).
Statistical analysis
Drug concentrations inhibiting parasite growth by 50%
(IC50) were calculated using nonlinear regression analy-
sis of log-based dose-response curves (Riasmart; Pack-
ard). Mann-Whitney U-test was used to compare
median IC50 between two groups and Kruskal Wallis in
case of multiple groups. Fisher’s exact test was used for
comparison of frequencies between groups when catego-
rical variables were defined. All analysis was done with
GraphPad Prism 5.0.
Nucleotide sequence accession numbers
Nucleotide sequence of new ms4760 genotypes were
deposited in the GenBank database under accession
numbers GQ845118, GQ845119 and GQ465284.
Results and discussion
A total of 98 clinical P. falciparum isolates were col-
lected between 2006 and 2008. All isolates were geno-
typed using six microsatellites loci (Pf2689, Pf2802,
C4M69, C4M79, TRAP and 7A11) to exclude polyclonal
infections, leaving 79 monoclonal isolates. Ten different
pfnhe1 ms4760 microsatellites profiles were found in
these 79 isolates (Table 1), including three not pre-
viously described (ms4760-63, -64, and -65). The most
prevalent profile was ms4760-7, found in 68.3% (n = 54/
79) of the isolates, followed by profiles ms4760-1 (7.6%,
n = 6/79), ms4760-6 (7.6%, n = 6/79) and ms4760-3
(6.3%, n = 5). The number of DNNND repeats in the 10
pfnhe1 profiles varied from zero to four, and three
repeats were more common accounting for 72.1% (n =
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Table 1 Sequence polymorphism and distribution of the 10 Pfnhe-1 ms4760 haplotypes observed in the 79 Vietnamese parasite isolates
No. Genotype profile Sequence N (freq.)
DNNND repeat NHNDNHNNDDD repeat
ms-1: KKKKISGSNNDNN DNNND DNNND NHNDDKNNKNDDD NHNDNHNNDDD NHNDNHNNDDD NNNDNHNDDDNNSSHY 6(7.6)
ms-3: KKKKISGSNNDNN DNNND DKNNKNDDD NHNDNHNNDDD NHNDNHNNDDD NNNDNHNDDDNNSSHY 5(6.3)
ms-5: KKKKISGSNNDNN DNNND DNNND DNNND DNNND NHNDDKNNKNDDD NHNDNHNNDDD NNDNHNDDDNNSSHY 1(1.3)
ms-6: KKKKISGSNNDNN DNNND DNNND NHNDDKNNKNDDD NHNDNHNNDDD NNNDNHNDDDNNSSHY 6(7.6)
ms-7: KKKKISGSNNDNN DNNND DNNND DNNND NHNDDKNNKNDDD NHNDNHNNDDD NNNDNHNDDDNNSSHY 54(68.3)
ms-18: KKKKKSGSNNDNN DNNND DNNND NHNDDKNNKNDDD NHNDNHNNDDD NHNDNHNNDDD NNNDNHNDDDNNSSHY 2(2.5)
ms-49: KKKKISGSNNDNN DNNND DNNND DNNND NHNDDKNNNNDDD NHNDNHNNDDD NNNDNHNDDDNNSSHY 1(1.3)
ms-63: KKKKISGSNNDSN DNNND DNNND DNNND DNNND NHNDDKNNKNDDD NHNDNHNNDDD NNNDNHNDDDNNSSHY 1(1.3)
ms-64: KKKKISGSNNDNN DNNND DNNND NNNN D NHNDDKNNKNDDD NHNDNHNNDDD NNNDNHNDDDNNSSHY 2(2.5)
ms-65: KKKKISGSNNDNN D NHNDDKNNKNDDD NHNDNHNNDDD NHNDNHNNDDD NNNDNHNDDDNNSSHY 1(1.3)
















57/79) of the isolates. In addition, the majority of iso-
lates (83.5%; n = 66/79) had a single repeat of
NHNDNHNNDDD while the remaining had two repeats
(16.4%; n = 13/79). The overrepresentation of parasite
isolates having three DNNND and one
NHNDNHNNDDD repeat was due to the high fre-
quency of the profile 7 among isolates. This observation
is in line with previous studies in which the haplotype 7
was found to be predominant in samples from Asia
[8,15,16]. Parasites with this most abundant ms4760
haplotype were associated with increased QN IC50
[15,16]. Then, the reduced genetic diversity of Pfnhe1
profiles towards three DNNND repeats in our study
would be suggestive of a low level QN responsiveness.
In the absence of clear clinical resistance, strict cut-off
level for in vitro QN resistance has not been yet defined.
Then, different arbitrary cut-off points of 800 nM, 500 nM
or 300 nM have been proposed depending on the origin of
isolates and the methodology used [29]. In this study, meth-
odologies used for the parasite culture and to assay drug
response were standardized to be used in the reference
laboratory and in the field. The QN susceptibility of three
strains (3D7, Dd2 and K1) that display different QN sensi-
tivity was measured by the HRP2 ELISA assay using the
same batches of pre-dosed drug plates than that used in the
field. The IC50 values for 3D7, K1 and Dd2 were 126.3 ± 0.4
nM, 825.0 ± 76.8 nM and 1192.0 ± 74.3 nM, respectively.
These results were comparable with those obtained using
the gold standard isotopic assay (127.1 ± 12.5 nM for 3D7,
857.4 ± 31.5 nM for K1 and 1148.8 ± 111.7 nM for Dd2)
and were consistent with the separation of the 3D7 and Dd2
strains respectively into the QNS and QNR categories and
with the intermediate QN susceptibility of the K1 strain.
Then, the QN cut-off value in this study was set at 800 nM.
Fifty-one monoclonal isolates were successfully evalu-
ated for in vitro susceptibilities to QN. The IC50 median
[25-75% interquartiles] in vitro activity of QN was 650
nM [517-928]. A substantial proportion of the isolates
(35.3%, n = 20) showed reduced QN sensitivity with
IC50 above 800 nM (median of 972.9 nM [914.2-1028.8
nM]). Isolates originating from another hyper endemic
part of Southeast Asia and with high QN IC50 values
were also recently reported [16]. The observation of a
large proportion of isolates from South central Viet
Nam with harmful decreased QN responsiveness is in
line with a clinical study conducted in the neighbouring
Lam Dong province, in which reduced sensitivity to QN
expressed as a lower rate of parasite clearance was
observed [5]. The decreasing sensitivity to QN observed
here suggested that isolates have been exposed to a
strong QN pressure in this part of Viet Nam. In Viet
Nam, QN has been consistently used alone or in combi-
nation until 2006 and is now reserved as a second-line
treatment of uncomplicated and severe falciparum
malaria [30]. However, when the study was conducted,
QN was still available in local shops (personnal data);
thus its use as self-medication would be a factor in the
persistence of QN resistance especially in rural and
remote areas, which have limited basic health care facil-
ities [31-33].
Out of the 51 isolates that were successfully tested for
drug susceptibility, seven pfnhe1 ms4760 profiles were
detected. The distribution of pfnhe1 profiles was not sta-
tistically different than that found in the whole set of
parasites (n = 79). The pfnhe1 profile 7 was still predo-
minant, accounting for 76.5% (n = 39/51), followed by
haplotypes 6 (9.8%, n = 5/51), 1 (3.9%, n = 2/51) and 3
(3.9%, n = 2/51). The other ms4760 haplotypes (profiles
5, 18 and 65) were found only in one isolate each (2%, n
= 1/51). Significant associations were found between
pfnhe1 polymorphisms and susceptibility to QN. Isolates
with two or more DNNND were less susceptible to QN
than those harbouring zero or one DNNND repeats:
median QN IC50 = 682 nM [535-941] vs. median QN




Figure 2 Association between QN IC50 (nM) of parasite isolates
and the number of (A) DNNND repeats or (B) NHNDNHNNDDD
repeats in Pfnhe-1 . (A) Median QN IC50 of isolates with 2 or more
DNNND repeats are significantly higher than isolates with less than
2 DNNND (p = 0.015) (B) Median QN IC50 of isolates with 1
NHNDNHNNDDD repeat are significantly higher than isolates
harbouring 2 repeats (p < 0.01).
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respectively. In addition, isolates having one
NHNDNHNNDDD repeat presented significantly
reduced QN susceptibility (median QN IC50= 704 nM
[550-933]) than those who had two (median QN IC50=
375 nM [200-482]) (Figure 2B; p < 0.01). These results
are in accordance with previous studies performed with
culture-adapted isolates which reported a link between
the number of DNNND repeat and QN responsiveness
[8,15,16], but this is the first time that this association is
reported on freshly collected clinical isolates. In addi-
tion, it should be mentioned that the majority of our
parasites isolates contained the pfcrt CQR associated
genotype (84%) and wild-type pfmdr1 (> 95%) thus pre-
venting analysis of associations with these mutations.
Given the multifactorial basis of QNR and the strain-
specific contribution of pfnhe1 to QN phenotype
[7,14,33-36], it may be suggested that the association
between pfnhe1 and QN responses in our study may has
been rendered possible due to a reduced genetic diver-
sity, highlighed by the high frequency of the likely well-
adapted pfnhe1 variant, namely ms4760-7. Indeed, this
profile with three DNNND repeats is currently found
with high frequency among Asian parasites [8,15,16]. In
particular, when isolates were collected from a relatively
small geographic region with the same drug use history
the frequency of haplotype 7 accounted for almost 50%
[16] up to 68% in our study. If this genotype is actually
linked to the phenotype of a decrease susceptibility to
QN with a high penetrance, its overrepresentation in
Asian isolates may explain why the association of pfnhe1
polymorphism with QN susceptibility has always been
observed, whatever the methodology used, i.e. use of
culture-adapted parasite isolates [16] or freshly collected
clinical isolates [this study]. All together, this would sug-
gest that the prevalence of profile 7 may constitute a
good marker of QNR spread at least in Viet Nam and
likely in South-East Asia.
To complete this hypothesis of a relationship between
QN susceptibility and the frequency of haplotype 7, sam-
ples were further examined according to the area where
they were collected. Among isolates with QN IC50, 32
were from Bu Dang, 12 were from Phuoc Long and 7
were from Dak R’Lap district. QN susceptibilities or
frequencies of isolates with reduced QN susceptibility
were statistically different between the three districts
(Table 2). The Phuoc Long district, which presented the
highest median QN IC50, with half of the isolates having
the highest values of IC50 (> 800 nM), had also the high-
est percentage of isolates carrying the pfnhe1 haplotype 7
(93.7%). Although concerning less isolates, the Dak R’Lap
district presented the lowest frequency of isolates with
reduced susceptibility to QN (28.6%) and the lowest fre-
quency of profile 7 (46.7%) compared to other districts (p
< 0.01). Finally the Bu Dang district, with an intermediate
frequency of 37.5% of isolates having QN IC50 > 800 nM
had also an intermediate level of profile 7 frequency
(72.9%). This appears to agree with the malaria epide-
miology in these areas where a higher number of cases of
malaria has been reported in Phuoc Long compared to
Dak R’ Lap and Bu Dang [33]. In this study, the monitor-
ing site in Phuoc Long was located in a rural and remote
forested region and was 10 km far from border with
Cambodia, where there is significant population move-
ment [37]. The neighbouring Kratie and Modulkiri Cam-
bodian provinces are characterized by intense malaria
transmission [38] and multidrug resistant P. falciparum
[39]. Consequently, the high proportion of QNR found
among isolates from Phuoc Long may either be due to
inherently QN-resistant parasite population or to possi-
ble spread of resistant isolates from the neighbouring
Cambodia. In particular, migrant workers have been sus-
pected as a leading cause of malaria transmission in these
areas as they are at particularly high risk of malaria and
may have poor access to preventive and therapeutic ser-
vices [40]. Then, in the presence of substantial popula-
tion movement, high transmission rate and the long
terminal half-life QN, selection of resistant strains may
be accelerated in this area.
According to the present study and the previous study
of Meng et al [16], the typical Asian haplotype 7
appears likely well-adapted to high drug pressure areas,
and the local correlation we found between its fre-
quency and the frequency of isolates with reduced sus-
ceptibility to QN would suggest that it may constitute a
good genetic marker to evaluate the dissemination of
QNR in this part of the world.
Table 2 QN susceptibility and frequency of pfnhe-1 haplotype 7 among the three geographical districts
District Median QN IC50 (nM)
[interquartile range]
Percentage of QNR isolates (n/N) Percentage of haplotype 7 (n1/N1)
Dak R’Lap 535[418-849] 28.6 (2/7) 46.7 (7/15)*
Bu Dang 618[450-906] 37.5 (12/32) 72.9 (34/48)
Phuoc Long 770[595-986] 50.0 (6/12) 93.7 (15/16)
1. n = number of QNR parasite isolates; N = number of parasite isolates with QN IC50.
2. n1 = total number of parasite isolates carrying the haplotype 7; N1 = number of parasite isolates genotyped for pfnhe-1.
* The percentage of profile 7 is lower in isolates from Dak R’Lap district than that of isolates from Bu Dang or Phuoc Long districts (p < 0.01).
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In conclusion, the mechanism of QN resistance is
complex with polymorphisms in multiple genes contri-
buting to the phenotype. However, to date no single
mutation of set of polymorphisms has been shown to be
a robust marker for in vitro QN sensitivity of field iso-
lates. In the present study, the frequency of haplotype 7
was the most relevant but additional markers are needed
to define parasite as QNR or QNS. Further studies are
needed to confirm whether the haplotype 7 is necessary
for the emergence QN resistance and can be used in
monitoring the QNR spread in South East Asia.
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